Evidence map›Paper›PMID 35701056›Full record

Trial reportBMJ open2022

It depends on how you tell: a qualitative diagnostic analysis of the implementation climate for community-wide mass drug administration for soil-transmitted helminth.

Euripide Avokpaho, Sarah Lawrence, Amy Roll, Angelin Titus, Yesudoss Jacob, Saravanakumar Puthupalayam Kaliappan, Marie Claire Gwayi-Chore, Félicien Chabi, Comlanvi Innocent Togbevi, Abiguel Belou Elijan and 7 more

Registry-linked trialOpen access · goldAbstract readClinical Trial
In one paragraph

Trial report in BMJ open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT03014167 (Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths), which is not on this map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
1.1field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03014167 phase3completednot on this map

Field Studies on the Feasibility of Interrupting the Transmission of Soil-transmitted Helminths (STH) DeWorm3 Project

TypeinterventionalSponsorUniversity of WashingtonRan2017 to 2024Enrolled357,716ConditionsHelminthiasis, FilariasisArmsAlbendazole
3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 6 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 4 institutions in 4 countries.

Euripide AvokpahoInstitut de Recherche Clinique du Bénin, Abomey-Calavi, Benin.
Sarah LawrenceDepartment of Pediatrics, University of Washington, Seattle, Washington, USA.
Amy RollDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Angelin TitusThe Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College Vellore, Vellore, India.
Yesudoss JacobThe Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College Vellore, Vellore, India.
Saravanakumar Puthupalayam KaliappanThe Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College Vellore, Vellore, India.
Marie Claire Gwayi-ChoreDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Félicien ChabiInstitut de Recherche Clinique du Bénin, Abomey-Calavi, Benin.
Comlanvi Innocent TogbeviInstitut de Recherche Clinique du Bénin, Abomey-Calavi, Benin.
Abiguel Belou ElijanInstitut de Recherche Clinique du Bénin, Abomey-Calavi, Benin.
Providence NindiBlantyre Institute for Community Outreach, Blantyre, Malawi.
Judd L WalsonDepartment of Global Health, University of Washington, Seattle, Washington, USA.
Sitara Swarna Rao AjjampurThe Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College Vellore, Vellore, India.
Moudachirou IbikounleInstitut de Recherche Clinique du Bénin, Abomey-Calavi, Benin.
Khumbo KaluaBlantyre Institute for Community Outreach, Blantyre, Malawi.
Kumudha AruldasThe Wellcome Trust Research Laboratory, Division of Gastrointestinal Sciences, Christian Medical College Vellore, Vellore, India.
Arianna Rubin MeansDepartment of Global Health, University of Washington, Seattle, Washington, USA aerubin@uw.edu.ORCID 0000-0002-4087-7080
Christian Medical College, Vellore · INUniversity of Washington · USBlantyre Institute for Community Ophthalmology · MWUniversité d'Abomey-Calavi · BJ

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesCurrent soil-transmitted helminth (STH) morbidity control guidelines primarily target deworming of preschool and school-age children. Emerging evidence suggests that community-wide mass drug administration (cMDA) may interrupt STH transmission. However, the success of such programmes depends on achieving high treatment coverage and uptake. This formative analysis was conducted to evaluate the implementation climate for cMDA and to determine barriers and facilitators to launch. SETTINGS: Prior to the launch of a cMDA trial in Benin, India and Malawi.

participantsCommunity members (adult women and men, children, and local leaders), community drug distributors (CDDs) and health facility workers.

designWe conducted 48 focus group discussions (FGDs) with community members, 13 FGDs with CDDs and 5 FGDs with health facility workers in twelve randomly selected clusters across the three study countries. We used the Consolidated Framework for Implementation Research to guide the design of the interview guide and thematic analysis.

resultsAcross all three sites, aspects of the implementation climate that were facilitators to cMDA launch included: high community member demand for cMDA, integration of cMDA into existing vaccination campaigns and/or health services, and engagement with familiar health workers. Barriers to launching cMDA included mistrust towards medical interventions, fear of side effects and limited perceived need for interrupting STH transmission. We include specific recommendations from community members regarding cMDA distribution sites, personnel requirements, delivery timing and incentives, leaders to engage and methods for mobilising participants.

conclusionsPrior to launching the cMDA programme as an alternative to school-based MDA, cMDA was found to be generally acceptable across diverse geographical and demographic settings. Community members, CDDs and health workers felt that engaging communities and tailoring programmes to the local context are critical for success. Potential barriers may be mitigated by identifying local concerns and addressing them via targeted community sensitisation prior to implementation. TRIAL REGISTRATION NUMBER: NCT03014167; Pre-results.

Indexed as

HelminthiasisHelminthsAdultAnimalsChildChild, PreschoolFemaleFocus GroupsHumansMaleMass Drug AdministrationSoilSoilcommunity child healthpublic healthqualitative researchtropical medicine

Identifiers

PMID35701056
PMCPMC9198697
OpenAlexW4282839455

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.